Zenas Biopharma’s lead autoimmune drug has been tied to a 95% reduction in a type of brain lesions over 12 weeks in a phase 2 multiple sclerosis (MS) study.  | Zenas Biopharma’s lead autoimmune drug ...

Scientists have found blood protein signals that may flag multiple sclerosis up to seven years before symptoms begin.

"Multiple sclerosis: three trials to watch" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

People with multiple sclerosis (MS) have altered levels of several key bacteria in the mouth, a new study reports.

The first patient has been dosed in a Phase 1 trial testing the experimental CAR T-cell therapy obecabtagene autoleucel for progressive MS.

With ads everywhere for pro- or pre-biotic foods and supplements, most people are familiar with the gut microbiome—the ...

UCSF study finds MS starts damaging the brain years before symptoms appear. Early immune attack on myelin and key proteins ...

A gene on the X chromosome revs up inflammation in the female brain, which may explain why rates of multiple sclerosis are ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients who registered more persistent paramagnetic rim ...

By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for ...

An analysis of data from phase 3 randomized controlled trials showed that among individuals with comparable disease duration, inflammatory disease activity was significantly lower in older trial ...

A new study indicates that amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) have an extremely high geographic association, even after controlling for race, gender, wealth, latitude, and ...